Ibrahim Halil Sahin

16PUBLICATIONS
48CO-AUTHORS
Cancer geneticsCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Jul 31, 2026
Genomic landscape and clinical characteristics of ERBB2/HER2-mutated colorectal cancers.

|Dec 15, 2025
Rechallenge With an Epidermal Growth Factor Receptor Inhibitor in Metastatic Colorectal Cancer: A Systematic Review and Meta-Analysis.

Amy H Huang, Gin Yi Lee, Chuan Angel Lu

|Jul 31, 2025
Investigating incidence of RAS/RAF and PIK3CA alterations in HER2-amplified colorectal cancer: a comprehensive analysis.

Svea Cheng, Cyndi Gonzales Gomez, Morgan Ferrell

|Jan 27, 2025
Shedding Light on the Prognostic and Predictive Value of Circulating Tumor DNA for Management of Patients with Early-Stage Colon Cancer.

Rami Yanes, Turcin Saridogan, Vikram Gorantla

|May 13, 2024
Targeting KRAS Oncogene for Patients With Colorectal Cancer: A New Step Toward Precision Medicine.

Ibrahim Halil Sahin, Turcin Saridogan, Ruveyda Ayasun

|Feb 13, 2024
Differential Responses to Immune Checkpoint Inhibitors are Governed by Diverse Mismatch Repair Gene Alterations.

Moh'd M Khushman, Michael D Toboni, Joanne Xiu

Pageof 3

Frequent Collaborators

2 joint publications

Anwaar Saeed

2 joint publications

Richard Kim

2 joint publications

Dennis Hsu

2 joint publications

Turcin Saridogan